These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25751063)

  • 1. A versatile modular vector system for rapid combinatorial mammalian genetics.
    Albers J; Danzer C; Rechsteiner M; Lehmann H; Brandt LP; Hejhal T; Catalano A; Busenhart P; Gonçalves AF; Brandt S; Bode PK; Bode-Lesniewska B; Wild PJ; Frew IJ
    J Clin Invest; 2015 Apr; 125(4):1603-19. PubMed ID: 25751063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
    Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
    Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing CRISPR/Cas9 for in situ functional assays.
    Malina A; Mills JR; Cencic R; Yan Y; Fraser J; Schippers LM; Paquet M; Dostie J; Pelletier J
    Genes Dev; 2013 Dec; 27(23):2602-14. PubMed ID: 24298059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9.
    Abrahimi P; Chang WG; Kluger MS; Qyang Y; Tellides G; Saltzman WM; Pober JS
    Circ Res; 2015 Jul; 117(2):121-8. PubMed ID: 25940550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.
    Valletta S; Dolatshad H; Bartenstein M; Yip BH; Bello E; Gordon S; Yu Y; Shaw J; Roy S; Scifo L; Schuh A; Pellagatti A; Fulga TA; Verma A; Boultwood J
    Oncotarget; 2015 Dec; 6(42):44061-71. PubMed ID: 26623729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR used to create mouse models.
    Cancer Discov; 2014 Nov; 4(11):1248-9. PubMed ID: 25367932
    [No Abstract]   [Full Text] [Related]  

  • 10. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo.
    Aubrey BJ; Kelly GL; Kueh AJ; Brennan MS; O'Connor L; Milla L; Wilcox S; Tai L; Strasser A; Herold MJ
    Cell Rep; 2015 Mar; 10(8):1422-32. PubMed ID: 25732831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RLIP with CRISPR/Cas9 controls tumor growth.
    Singhal J; Chikara S; Horne D; Awasthi S; Salgia R; Singhal SS
    Carcinogenesis; 2021 Feb; 42(1):48-57. PubMed ID: 32426802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma.
    Brandt LP; Albers J; Hejhal T; Catalano A; Wild PJ; Frew IJ
    PLoS One; 2017; 12(10):e0186102. PubMed ID: 28982163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast Organoids.
    Dekkers JF; Whittle JR; Vaillant F; Chen HR; Dawson C; Liu K; Geurts MH; Herold MJ; Clevers H; Lindeman GJ; Visvader JE
    J Natl Cancer Inst; 2020 May; 112(5):540-544. PubMed ID: 31589320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future.
    Mao XY; Dai JX; Zhou HH; Liu ZQ; Jin WL
    Oncotarget; 2016 May; 7(22):33461-71. PubMed ID: 26993776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
    Dubrot J; Lane-Reticker SK; Kessler EA; Ayer A; Mishra G; Wolfe CH; Zimmer MD; Du PP; Mahapatra A; Ockerman KM; Davis TGR; Kohnle IC; Pope HW; Allen PM; Olander KE; Iracheta-Vellve A; Doench JG; Haining WN; Yates KB; Manguso RT
    Immunity; 2021 Mar; 54(3):571-585.e6. PubMed ID: 33497609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapting CRISPR/Cas9 for functional genomics screens.
    Malina A; Katigbak A; Cencic R; Maïga RI; Robert F; Miura H; Pelletier J
    Methods Enzymol; 2014; 546():193-213. PubMed ID: 25398342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Considerations for Using Pooled Lentiviral CRISPR Libraries.
    McDade JR; Waxmonsky NC; Swanson LE; Fan M
    Curr Protoc Mol Biol; 2016 Jul; 115():31.5.1-31.5.13. PubMed ID: 27366891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.
    Kabadi AM; Ousterout DG; Hilton IB; Gersbach CA
    Nucleic Acids Res; 2014 Oct; 42(19):e147. PubMed ID: 25122746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modular lentiviral and retroviral construction system to rapidly generate vectors for gene expression and gene knockdown in vitro and in vivo.
    Geiling B; Vandal G; Posner AR; de Bruyns A; Dutchak KL; Garnett S; Dankort D
    PLoS One; 2013; 8(10):e76279. PubMed ID: 24146852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.